Literature DB >> 20096797

Validating and troubleshooting ocular in vitro toxicology tests.

Frank A Barile1.   

Abstract

In vitro organotypic models for testing ocular irritants have warranted sufficient interest as methods to replace in vivo ocular testing. The in vitro organotypic models claim to maintain short-term normal physiological and biochemical functions of the mammalian cornea in an isolated system. In these test methods, damage by the test substance is assessed by quantitative measurements of changes in corneal opacity and permeability using opacitometry and spectrophotometry, respectively. Both measurements are used quantitatively for irritancy classification for prediction of the in vivo ocular irritation potential of a test substance. Examples of organotypic models that incorporate these criteria include: the bovine corneal opacity and permeability (BCOP) assay, the isolated chicken eye (ICE) test method and the isolated rabbit eye (IRE) assay. A fourth method, the hen's egg test-chorioallantoic membrane (HET-CAM) assay, differs in the evaluation criteria but is also normally included among this class of in vitro protocols. Each of these protocols is discussed in detail as representative candidate in vitro methods for assessing ocular irritation and corrosion. The methodologies, protocol details, applications, and their validation status are discussed. A brief historical perspective of the development of original in vitro ocular testing models is also mentioned. More importantly, improving and troubleshooting the current techniques, in order to present the models as stand-alone in vitro tools for ocular toxicity assessment, is emphasized. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20096797      PMCID: PMC2849866          DOI: 10.1016/j.vascn.2010.01.001

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  32 in total

1.  The principles of weight of evidence validation of test methods and testing strategies. The report and recommendations of ECVAM workshop 58.

Authors:  Michael Balls; Patric Amcoff; Susanne Bremer; Silvia Casati; Sandra Coecke; Richard Clothier; Robert Combes; Raffaella Corvi; Rodger Curren; Chantra Eskes; Julia Fentem; Laura Gribaldo; Marlies Halder; Thomas Hartung; Sebastian Hoffmann; Leonard Schectman; Laurie Scott; Horst Spielmann; William Stokes; Raymond Tice; Drew Wagner; Valérie Zuang
Journal:  Altern Lab Anim       Date:  2006-12       Impact factor: 1.303

2.  Correlation of in vitro cytotoxicity with paracellular permeability in mortal rat intestinal cells.

Authors:  Roula Konsoula; Frank A Barile
Journal:  J Pharmacol Toxicol Methods       Date:  2006-06-16       Impact factor: 1.950

3.  In vitro ocular irritation toxicity study of some pesticides.

Authors:  P Budai; L Várnagy
Journal:  Acta Vet Hung       Date:  2000       Impact factor: 0.955

4.  Hen's egg chorioallantoic membrane test for irritation potential.

Authors:  N P Luepke
Journal:  Food Chem Toxicol       Date:  1985-02       Impact factor: 6.023

5.  The in vitro assessment of severe eye irritants.

Authors:  A B Burton; M York; R S Lawrence
Journal:  Food Cosmet Toxicol       Date:  1981-08

6.  Interlaboratory validation of the in vitro eye irritation tests for cosmetic ingredients. (1) Overview of the validation study and Draize scores for the evaluation of the tests.

Authors:  Y Ohno; T Kaneko; T Inoue; Y Morikawa; T Yoshida; A Fujii; M Masuda; T Ohno; M Hayashi; J Momma; T Uchiyama; K Chiba; N Ikeda; Y Imanishi; H Itakagaki; H Kakishima; Y Kasai; A Kurishita; H Kojima; K Matsukawa; T Nakamura; K Ohkoshi; H Okumura; K Saijo; K Sakamoto; T Suzuki; K Takano; H Tatsumi; N Tani; M Usami; R Watanabe
Journal:  Toxicol In Vitro       Date:  1999-02       Impact factor: 3.500

7.  Prediction of ocular irritancy of prototype shampoo formulations by the isolated rabbit eye (IRE) test and bovine corneal opacity and permeability (BCOP) assay.

Authors:  K J Cooper; L K Earl; J Harbell; H Raabe
Journal:  Toxicol In Vitro       Date:  2001-04       Impact factor: 3.500

8.  Evaluation of in vitro cytotoxicity and paracellular permeability of intact monolayers with mouse embryonic stem cells.

Authors:  Anthony R Calabro; Roula Konsoula; Frank A Barile
Journal:  Toxicol In Vitro       Date:  2008-03-29       Impact factor: 3.500

9.  Acute cytotoxicity testing with cultured human lung and dermal cells.

Authors:  F A Barile; M Cardona
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-09       Impact factor: 2.416

10.  The CTFA Evaluation of Alternatives Program: an evaluation of in vitro alternatives to the Draize primary eye irritation test. (Phase III) surfactant-based formulations.

Authors:  S D Gettings; R A Lordo; K L Hintze; D M Bagley; P L Casterton; M Chudkowski; R D Curren; J L Demetrulias; L C Dipasquale; L K Earl; P I Feder; C L Galli; S M Glaza; V C Gordon; J Janus; P J Kurtz; K D Marenus; J Moral; W J Pape; K J Renskers; L A Rheins; M T Roddy; M G Rozen; J P Tedeschi; J Zyracki
Journal:  Food Chem Toxicol       Date:  1996-01       Impact factor: 6.023

View more
  16 in total

1.  Development and clinical study of a self-dissolving microneedle patch for transcutaneous immunization device.

Authors:  Sachiko Hirobe; Hiroaki Azukizawa; Kazuhiko Matsuo; You Zhai; Ying-Shu Quan; Fumio Kamiyama; Hiroshi Suzuki; Ichiro Katayama; Naoki Okada; Shinsaku Nakagawa
Journal:  Pharm Res       Date:  2013-06-18       Impact factor: 4.200

Review 2.  [Eye irritation and chemical eye burns. Review of experimental and clinical studies].

Authors:  A K Cordes; M Frentz; N F Schrage
Journal:  Ophthalmologe       Date:  2011-10       Impact factor: 1.059

Review 3.  In vitro reconstructed 3D corneal tissue models for ocular toxicology and ophthalmic drug development.

Authors:  Yulia Kaluzhny; Mitchell Klausner
Journal:  In Vitro Cell Dev Biol Anim       Date:  2021-02-05       Impact factor: 2.416

Review 4.  The chicken chorioallantoic membrane model in biology, medicine and bioengineering.

Authors:  Patrycja Nowak-Sliwinska; Tatiana Segura; M Luisa Iruela-Arispe
Journal:  Angiogenesis       Date:  2014-08-20       Impact factor: 9.596

5.  Dynamic Contrast Microscopic Optical Coherence Tomography As a Novel Method for Assessing Corneal Epithelium During Exposure to Benzalkonium Chloride.

Authors:  Gwen Musial; Tabea Kohlfaerber; Martin Ahrens; Hinnerk Schulz-Hildebrandt; Philipp Steven; Gereon Hüttmann
Journal:  Transl Vis Sci Technol       Date:  2022-05-02       Impact factor: 3.048

Review 6.  Role of In Vitro Models for Development of Ophthalmic Delivery Systems.

Authors:  Shallu Kutlehria; Mandip Singh Sachdeva
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2021       Impact factor: 4.889

7.  Poly(2-hydroxyethyl methacrylate)-quercetin Conjugate as Biomaterial in Ophthalmology: An "ab initio" Study.

Authors:  Manuela Curcio; Giuseppe Cirillo; Ortensia Ilaria Parisi; Francesca Iemma; Umile Gianfranco Spizzirri; Ilaria Altimari; Nevio Picci; Francesco Puoci
Journal:  J Funct Biomater       Date:  2011-01-27

8.  Cultivation of human microvascular endothelial cells on topographical substrates to mimic the human corneal endothelium.

Authors:  Jie Shi Chua; Li Xiang Liew; Evelyn K F Yim
Journal:  J Funct Biomater       Date:  2013-03-21

Review 9.  Sensory irritation as a basis for setting occupational exposure limits.

Authors:  Thomas Brüning; Rüdiger Bartsch; Hermann Maximillian Bolt; Herbert Desel; Hans Drexler; Ursula Gundert-Remy; Andrea Hartwig; Rudolf Jäckh; Edgar Leibold; Dirk Pallapies; Albert W Rettenmeier; Gerhard Schlüter; Gisela Stropp; Kirsten Sucker; Gerhard Triebig; Götz Westphal; Christoph van Thriel
Journal:  Arch Toxicol       Date:  2014-09-03       Impact factor: 5.153

10.  Preliminary studies on validation of calu-3 cell line as a model for screening respiratory mucosa irritation and toxicity.

Authors:  Chibueze Ihekwereme; Charles Esimone; Di Shao; Remigius U Agu
Journal:  Pharmaceutics       Date:  2014-06-13       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.